Clinical Trial Update: Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating a bioresorbable polymer-coated everolimus-eluting stent in high bleeding risk patients undergoing PCI with 1-month dual antiplat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• bioresorbable polymer-coated EES (everolimus-eluting stent)

Snippet

Sponsor: Humanitas Hospital, Italy | Conditions: Coronary Artery Disease, Acute Coronary Syndrome | Phase 4 | Status: UNKNOWN